Track topics on Twitter Track topics that are important to you
Natalie Sacks will resign from her position as chief medical officer of Aduro Biotech (NASDAQ: ADRO) effective Oct. 1, the cancer immunotherapy developer announced Wednesday. Berkeley, CA-based Aduro gave no reason for the resignation, but said that Sacks will continue to advise the company through a consulting agreement. Sacks joined Aduro in 2016. Last year, […]
Original Article: Aduro Biotech’s Chief Medical Officer Sacks to Resign in OctoberNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...